We believe in excellence, and we measure it by results. Our clients know that our dry powder aerosol generating platform, PreciseInhale, delivers regional lung data of a quality far beyond other inhalation technologies. PreciseInhale lets them carry out a full PK study using just 50-100 mg of test substance delvering results with a typical standard deviation of <10%.SD. Our in vitro capabilities are widely recognized as world-leading, bringing clients closer than ever to full IVIVC. PreciseInhale can include a series of exposure modules (from in vitro through to in vivo to clinical.) It can generate respirable dry powder aerosols from preclinical cell studies all the way through to human clinical trials, providing a translational ladder for inhalation R&D programs. Visit our website: http://www.inhalation.se/ Visit our labs: We welcome visitors to our labs in Stockholm, Sweden Kliniskt Forskningscentrum KFC Novum plan 6 hiss A Hälsovägen 7 141 57 Huddinge, Sweden Visitor entrance, Blickagången 6, elevator E, level 6